IL220513A - Composition for cutaneous application comprising calcipotriol and use thereof - Google Patents

Composition for cutaneous application comprising calcipotriol and use thereof

Info

Publication number
IL220513A
IL220513A IL220513A IL22051312A IL220513A IL 220513 A IL220513 A IL 220513A IL 220513 A IL220513 A IL 220513A IL 22051312 A IL22051312 A IL 22051312A IL 220513 A IL220513 A IL 220513A
Authority
IL
Israel
Prior art keywords
calcipotriol
composition
cutaneous application
cutaneous
application
Prior art date
Application number
IL220513A
Other languages
Hebrew (he)
Other versions
IL220513A0 (en
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of IL220513A0 publication Critical patent/IL220513A0/en
Publication of IL220513A publication Critical patent/IL220513A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL220513A 2009-12-22 2012-06-19 Composition for cutaneous application comprising calcipotriol and use thereof IL220513A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/DK2009/000266 WO2011076206A1 (en) 2009-12-22 2009-12-22 Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture

Publications (2)

Publication Number Publication Date
IL220513A0 IL220513A0 (en) 2012-08-30
IL220513A true IL220513A (en) 2016-05-31

Family

ID=44194970

Family Applications (1)

Application Number Title Priority Date Filing Date
IL220513A IL220513A (en) 2009-12-22 2012-06-19 Composition for cutaneous application comprising calcipotriol and use thereof

Country Status (13)

Country Link
EP (1) EP2515912A4 (en)
JP (1) JP5548275B2 (en)
CN (1) CN102770143B (en)
AU (1) AU2009357263B2 (en)
BR (1) BR112012015447A2 (en)
CA (1) CA2785249A1 (en)
HK (1) HK1177695A1 (en)
IL (1) IL220513A (en)
MX (1) MX2012007227A (en)
NZ (1) NZ601002A (en)
RU (1) RU2500387C1 (en)
WO (1) WO2011076206A1 (en)
ZA (1) ZA201204619B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107643354B (en) * 2016-07-22 2022-02-01 重庆华邦胜凯制药有限公司 Separation and determination method of calcipotriol starting material A and related impurities
CN106265511A (en) * 2016-08-22 2017-01-04 江苏知原药业有限公司 A kind of calcipotriol betamethasone self-micro emulsion formulation of excellent performance
CN106265485A (en) * 2016-08-22 2017-01-04 江苏知原药业有限公司 A kind of calcipotriol compositions of improved stability
CN106344589B (en) * 2016-11-10 2019-11-26 江苏知原药业有限公司 A kind of Calcipotriol betamethasone composition of improved stability
CN108904445A (en) * 2018-08-06 2018-11-30 江苏知原药业有限公司 Its salts nano suspending liquid
WO2022040773A1 (en) * 2020-08-26 2022-03-03 Canadian Nano Pharmaceutical Technology Inc. Nano-emulsion based compositions, methods for their preparation and their use in delivery of active ingredients
CN115350151B (en) * 2022-09-29 2023-09-12 湖北欣泽霏药业有限公司 High-stability alfacalcidol liquid oral preparation and preparation method thereof
CN116473985A (en) * 2023-03-29 2023-07-25 暨南大学 Polyene antifungal pharmaceutical composition and application thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763426A (en) * 1993-01-15 1998-06-09 Leo Pharmaceutical Products Ltd. Crystalline form of a vitamin D analogue
JP3340310B2 (en) * 1996-03-28 2002-11-05 株式会社資生堂 Composite emulsion and method for producing the same
WO1999029326A1 (en) * 1997-12-09 1999-06-17 Chugai Seiyaku Kabushiki Kaisha Creams containing vitamin d3 derivatives
EP1051974A4 (en) * 1997-12-09 2001-09-12 Chugai Pharmaceutical Co Ltd Lotions containing vitamin d 3 derivatives
US5990100A (en) * 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US6537980B1 (en) * 1999-04-23 2003-03-25 Leo Pharmaceutical Products Ltd. Vitamin D analogues and their pharmaceutical use
JP2001025359A (en) * 1999-07-15 2001-01-30 Mitsubishi-Kagaku Foods Corp O/w/o type emulsion composition and its production
AU2006256860B2 (en) * 2005-06-10 2012-04-19 Galderma S.A. Controlled release of a drug through skin on the basis of a topical composition comprising a drug, a film-forming silicone and at least one volatile solvent
WO2006138056A1 (en) * 2005-06-15 2006-12-28 Apollo Pharmaceutical, Inc. Pharmaceutical composition comprising a mahonia aquifolium extract for the treatment of psoriasis
FR2893847B1 (en) * 2005-11-30 2010-10-29 Galderma Sa SPRAY COMPOSITION COMPRISING VITAMIN D DERIVATIVE AND OILY PHASE
JP4913487B2 (en) * 2006-07-07 2012-04-11 ポーラ化成工業株式会社 Cosmetics characterized by a feeling of use
FR2909284B1 (en) * 2006-11-30 2012-09-21 Galderma Sa NOVEL VASELIN-FREE OINTMENTAL COMPOSITIONS COMPRISING VITAMIN D DERIVATIVE AND POSSIBLY STEROID ANTI-INFLAMMATORY
FR2911781B1 (en) * 2007-01-26 2009-03-20 Fabre Pierre Dermo Cosmetique DERMATOLOGICAL EMULSION AND PREPARATION METHOD
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP1970049A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D and corticosteroid

Also Published As

Publication number Publication date
CA2785249A1 (en) 2011-06-30
EP2515912A1 (en) 2012-10-31
IL220513A0 (en) 2012-08-30
BR112012015447A2 (en) 2016-03-15
CN102770143A (en) 2012-11-07
RU2500387C1 (en) 2013-12-10
ZA201204619B (en) 2013-09-25
CN102770143B (en) 2014-11-05
AU2009357263B2 (en) 2015-04-09
HK1177695A1 (en) 2013-08-30
AU2009357263A1 (en) 2012-07-19
JP5548275B2 (en) 2014-07-16
WO2011076206A1 (en) 2011-06-30
MX2012007227A (en) 2012-07-30
EP2515912A4 (en) 2013-12-25
NZ601002A (en) 2014-09-26
JP2013515017A (en) 2013-05-02

Similar Documents

Publication Publication Date Title
HUE059796T2 (en) Psma-targeting compounds and uses thereof
PL2435503T3 (en) Curable silyl-group containing compositions and its use
PL2652025T3 (en) Drier composition and use thereof
PL3480273T3 (en) Adhesive compositions and use thereof
EP2412789A4 (en) Lubricant composition and use thereof
EP2563130A4 (en) Pesticidal composition and its use
EP2511333A4 (en) Rubber composition and uses thereof
IL220513A (en) Composition for cutaneous application comprising calcipotriol and use thereof
ZA201106299B (en) Composition comprising caftaric acid and/or derivatives thereof
EP2501697A4 (en) Benzoimidazole compounds and uses thereof
EP2402429A4 (en) Equol-producing bacterium and use thereof
EP2563131A4 (en) Pesticidal composition and its use
PL2521445T3 (en) Formulation and use thereof
GB0902429D0 (en) Compositions and their use
GB0908174D0 (en) Steroid containing composition and uses thereof
EP2410017A4 (en) Composition and element using same
GB0902173D0 (en) Compounds and their use
GB0909768D0 (en) Novel compounds and uses thereof
EP2615094A4 (en) Sesterterpene compounds and use thereof
GB0922510D0 (en) Compound and use
ZA201200260B (en) Polyphenylsulphone-polytetrafluroethylene compositions and use thereof
SI2246181T1 (en) Compound material and its use
GB2461611B (en) Composition and use thereof
EP2488179A4 (en) Nrf2 inhibitors and use thereof
GB0909792D0 (en) Composition and uses thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees